Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Change in Acquisitions & Divestments (2020 - 2024)

Xeris Biopharma Holdings' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $10.2 million for Q4 2024.

  • For the quarter ending Q4 2024, Change in Acquisitions & Divestments fell 31.76% year-over-year to $10.2 million, compared with a TTM value of $10.2 million through Sep 2025, down 77.25%, and an annual FY2024 reading of $40.2 million, up 0.59% over the prior year.
  • Change in Acquisitions & Divestments for Q4 2024 was $10.2 million at Xeris Biopharma Holdings, down from $15.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $34.6 million in Q1 2021, with the low at $5.0 million in Q1 2024.
  • Average Change in Acquisitions & Divestments over 5 years is $14.8 million, with a median of $11.3 million recorded in 2021.
  • Year-over-year, Change in Acquisitions & Divestments plummeted 80.66% in 2022 and then soared 117.86% in 2023.
  • Tracing XERS's Change in Acquisitions & Divestments over 5 years: stood at $17.8 million in 2020, then tumbled by 41.14% to $10.5 million in 2021, then decreased by 11.43% to $9.3 million in 2022, then surged by 61.29% to $15.0 million in 2023, then tumbled by 31.76% to $10.2 million in 2024.
  • Per Business Quant, the three most recent readings for XERS's Change in Acquisitions & Divestments are $10.2 million (Q4 2024), $15.0 million (Q3 2024), and $10.0 million (Q2 2024).